We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
Cap. Flow
-$708M
Cap. Flow %
-17.33%
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.65%
2 Technology 23.8%
3 Financials 7.62%
4 Industrials 7.22%
5 Healthcare 6.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CORT icon
3426
Corcept Therapeutics
CORT
$12.6B
$23K ﹤0.01%
265
-1,011
-79% -$61K
LOGI icon
3427
Logitech
LOGI
$14.5B
$23K ﹤0.01%
245
-128
-34% -$13.3K
PLTK icon
3428
Playtika
PLTK
$812M
$22.9K ﹤0.01%
6,160
+1,186
+24% +$4.1K
BWMN icon
3429
Bowman Consulting
BWMN
$738M
$22.9K ﹤0.01%
784
-1,642
-68% -$51.7K
FINV
3430
FinVolution Group
FINV
$734M
$22.9K ﹤0.01%
+4,777
New +$23.6K
CRTO icon
3431
Criteo S.A.
CRTO
$798M
$22.9K ﹤0.01%
+1,251
New +$22.4K
ULH icon
3432
Universal Logistics Holdings
ULH
$440M
$22.9K ﹤0.01%
1,545
-14
-0.9% -$250
SGC icon
3433
Superior Group of Companies
SGC
$205M
$22.9K ﹤0.01%
1,742
-1,765
-50% -$21.2K
KRUS icon
3434
Kura Sushi USA
KRUS
$473M
$22.8K ﹤0.01%
396
-141
-26% -$7.71K
BZAI
3435
Blaize Holdings
BZAI
$74.4M
$22.8K ﹤0.01%
16,517
+609
+4% +$1.07K
ALT icon
3436
Altimmune
ALT
$595M
$22.7K ﹤0.01%
7,477
-7,011
-48% -$20.9K
TECX
3437
Tectonic Therapeutic
TECX
$463M
$22.7K ﹤0.01%
661
-253
-28% -$7.43K
CMTV
3438
Community BanCorp
CMTV
$229M
$22.7K ﹤0.01%
+581
New +$22.3K
STM icon
3439
STMicroelectronics
STM
$46.3B
$22.7K ﹤0.01%
303
-13,296
-98% -$800K
CFBK icon
3440
CF Bankshares
CFBK
$224M
$22.7K ﹤0.01%
692
-69
-9% -$2K
NKTX icon
3441
Nkarta
NKTX
$197M
$22.7K ﹤0.01%
8,009
+2,770
+53% +$7.8K
GDOT icon
3442
Green Dot
GDOT
$698M
$22.7K ﹤0.01%
1,677
-3,252
-66% -$40.7K
FINW icon
3443
FinWise Bancorp
FINW
$157M
$22.6K ﹤0.01%
1,562
-969
-38% -$14.4K
GENC icon
3444
Gencor Industries
GENC
$256M
$22.6K ﹤0.01%
1,516
-694
-31% -$10.3K
RANI icon
3445
Rani Therapeutics
RANI
$87.6M
$22.6K ﹤0.01%
29,743
+17,425
+141% +$15.4K
TRON
3446
Tron Inc
TRON
$683M
$22.6K ﹤0.01%
14,030
-18,898
-57% -$38.2K
SRI icon
3447
Stoneridge
SRI
$198M
$22.6K ﹤0.01%
3,084
+2,984
+2,984% +$20.5K
FWDI
3448
Forward Industries Inc
FWDI
$642M
$22.5K ﹤0.01%
5,342
+4,779
+849% +$21.3K
SIVR icon
3449
abrdn Physical Silver Shares ETF
SIVR
$4.35B
$22.5K ﹤0.01%
+400
New +$27.9K
CPS icon
3450
Cooper-Standard Automotive
CPS
$403M
$22.5K ﹤0.01%
831
-1,063
-56% -$31.3K

Similar funds

Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review

As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.

  • Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
  • Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
  • Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
  • Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.